Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Harrison

Showing results (461-470 of 583) with videos related to

Pageof 59
Sort By:
Hemasphere|May 10, 2021
Patient-reported Effects of Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2, on Myelofibrosis-related Symptoms and Health-related Quality of Life in the Randomized, Placebo-controlled, Phase III JAKARTA TrialRuben A Mesa, Nicolaas Schaap, Alessandro M Vannucchi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 21, 2019
Follow-up of Abnormal Estimated GFR Results Within a Large Integrated Health Care Delivery System: A Mixed-Methods StudyKim N Danforth, Erin E Hahn, Jeffrey M Slezak, et al.
JAMA Network Open|April 20, 2022
Association of the 2020 US Presidential Election With Hospitalizations for Acute Cardiovascular ConditionsMatthew T Mefford, Jamal S Rana, Kristi Reynolds, et al.
Hospital Pediatrics|October 26, 2022
Characteristics and Outcomes of Children Discharged With Nasoenteral Feeding TubesM Alex Ahearn, John R Stephens, Eric K Zwemer, et al.
Leukemia Research Reports|January 2, 2023
Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)Jumoke Okikiolu, Claire Woodley, Llywelyn Cadman-Davies, et al.
Obesity (Silver Spring, Md.)|August 13, 2011
Large size cells in the visceral adipose depot predict insulin resistance in the canine modelMorvarid Kabir, Darko Stefanovski, Isabel R Hsu, et al.
Journal of Neurology|October 16, 2019
ATP8A2-related disorders as recessive cerebellar ataxiaClaire Guissart, Alexander N Harrison, Mehdi Benkirane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2018
Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk FeaturesAnna L Godfrey, Peter J Campbell, Cathy MacLean, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 8, 2019
The effect of multiple recruitment contacts on response rates and patterns of missing data in a survey of bladder cancer survivors 6 months after cystectomyJoanna E Bulkley, Maureen O'Keeffe-Rosetti, Christopher S Wendel, et al.
British Journal of Haematology|June 26, 2014
Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012John T Reilly, Mary Frances McMullin, Philip A Beer, et al.
Pageof 59

Showing results (461-470 of 583) with videos related to

Sort By:
Pageof 59
Hemasphere|May 10, 2021
Patient-reported Effects of Fedratinib, an Oral, Selective Inhibitor of Janus Kinase 2, on Myelofibrosis-related Symptoms and Health-related Quality of Life in the Randomized, Placebo-controlled, Phase III JAKARTA TrialRuben A Mesa, Nicolaas Schaap, Alessandro M Vannucchi, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 21, 2019
Follow-up of Abnormal Estimated GFR Results Within a Large Integrated Health Care Delivery System: A Mixed-Methods StudyKim N Danforth, Erin E Hahn, Jeffrey M Slezak, et al.
JAMA Network Open|April 20, 2022
Association of the 2020 US Presidential Election With Hospitalizations for Acute Cardiovascular ConditionsMatthew T Mefford, Jamal S Rana, Kristi Reynolds, et al.
Hospital Pediatrics|October 26, 2022
Characteristics and Outcomes of Children Discharged With Nasoenteral Feeding TubesM Alex Ahearn, John R Stephens, Eric K Zwemer, et al.
Leukemia Research Reports|January 2, 2023
Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)Jumoke Okikiolu, Claire Woodley, Llywelyn Cadman-Davies, et al.
Obesity (Silver Spring, Md.)|August 13, 2011
Large size cells in the visceral adipose depot predict insulin resistance in the canine modelMorvarid Kabir, Darko Stefanovski, Isabel R Hsu, et al.
Journal of Neurology|October 16, 2019
ATP8A2-related disorders as recessive cerebellar ataxiaClaire Guissart, Alexander N Harrison, Mehdi Benkirane, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 29, 2018
Hydroxycarbamide Plus Aspirin Versus Aspirin Alone in Patients With Essential Thrombocythemia Age 40 to 59 Years Without High-Risk FeaturesAnna L Godfrey, Peter J Campbell, Cathy MacLean, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 8, 2019
The effect of multiple recruitment contacts on response rates and patterns of missing data in a survey of bladder cancer survivors 6 months after cystectomyJoanna E Bulkley, Maureen O'Keeffe-Rosetti, Christopher S Wendel, et al.
British Journal of Haematology|June 26, 2014
Use of JAK inhibitors in the management of myelofibrosis: a revision of the British Committee for Standards in Haematology Guidelines for Investigation and Management of Myelofibrosis 2012John T Reilly, Mary Frances McMullin, Philip A Beer, et al.
Pageof 59